Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-26

FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for Celecoxib (celecoxib), authorizing a generic version under the ANDA pathway. The action does not specif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

SUPPL AP for CELECOXIB (CELECOXIB)